Quick Takeaways
- Thomas A. Satterfield Jr. filed SCHEDULE 13G for Lantern Pharma Inc. Common Stock, $0.0001 par value per share (LTRN).
- Disclosed ownership: 5.1%.
- Date of event: 30 Mar 2026.
Thomas A. Satterfield Jr. - 30 Mar 2026 SCHEDULE 13G Report for Lantern Pharma Inc. Common Stock, $0.0001 par value per share (LTRN)
- Filing Manager
- Thomas A. Satterfield Jr.
- Reporting Manager
- Thomas A. Satterfield, Jr.
- Symbol
- LTRN
- Shares outstanding
- 11,176,471 shares
- Disclosed Ownership
- 570,000 shares
- Ownership
- 5.1%
- Form type
- SCHEDULE 13G
- Filing time
- 03 Apr 2026, 10:53:30 UTC
- Date of event
- 30 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Thomas A. Satterfield Jr. disclosed 5.1% ownership in Lantern Pharma Inc. Common Stock, $0.0001 par value per share (LTRN) on 30 Mar 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 03 Apr 2026, 10:53.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Thomas A. Satterfield, Jr. | 5.1% | 570,000 | 95,000 | 475,000 | /s/ Thomas A. Satterfield, Jr. | Thomas A. Satterfield, Jr. |